Sign in

NCT06856460Completed

The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults

Source: ClinicalTrials.gov · Last updated 13 Feb 2026

Brief summary (registry, in English)

Low glycemic index nutritional shakes have clinically shown to improve post-prandial glycemic responses in acute laboratory control studies. However, there is limited information on how replacing meals with low-glycemic index shake could impact glucose regulation in free-living adults consuming their own diets. The present study aims to examine the impact of adding the SP Glucose-Assist shake to the breakfast of non-diabetic overweight and obese adults. Subjects: 40 non-diabetic adults aged 25-65 years and body mass index ranging between 25-39 . Protocol: This is going to be a three-week study that will include a one-week self-selected diet, followed by two weeks of a breakfast supplement shake (standard process glucose assist) or control cereal oat breakfast.

Status (registry)
Completed
Study type
Interventional
Enrollment
46 (actual)
First submitted
25 Feb 2025
Start date
18 Mar 2025
Primary completion date
14 Nov 2025
Lead sponsor
Arizona State University
Diseases
Obesity
NCT number
NCT06856460

What you commit to

  • Study type: Interventional
  • Participants enrolled: 46
  • From 18 Mar 2025 to the primary completion date, 14 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Thyroid medication
  • Bariatric surgery
  • Medications of supplements that could affect body weight or appetite (i.e. Ozempic)

Other illness

  • Eating disorders
  • cancer
  • cardiovascular disease
  • renal disease
  • hepatic disease
  • Current infection requiring medication
  • Chronic, contagious, infectious diseases such as tuberculosis, Hepatitis A, B, C, or HIV

Lab values

  • glycated hemoglobin \>7%

Other

  • Body mass index ≤25 or ≥ 40
  • Night shifting work
  • Atypical meal pattern (not three meals a day or intermittent fasting)
  • Habitual strenuous exercise
  • Commuting by bicycle
  • Use of aspirin during the duration of the study
  • Intake of Vit C \>60 mg/day during the study
  • X-ray, MRI or CT appointment during the study duration
  • Participating in another study at the same time

Who the study is looking for

  • Body mass index 25-40
  • Eating pattern 3 meals a day
  • stable weight for the last 2 months (\<5 pounds fluctuation)
  • Willing to eat oat cereal for breakfast
  • glycated hemoglobin \<7%

Age in the registry: 25 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Arizona State University 850 PBC
Coordinator of this site? Confirm its status
PhoenixUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.